(Q43687545)

25 November 2017

title

Effect of treatment with prostaglandin E1 and N-acetylcysteine on pediatric liver transplant recipients: a single-center study (English)

1 reference

25 November 2017

1 reference

1 reference

Bucuvalas JC

1

1 reference

25 November 2017

Ryckman FC

2

1 reference

25 November 2017

Krug S

3

1 reference

25 November 2017

Alonso MH

4

1 reference

25 November 2017

Balistreri WF

5

1 reference

25 November 2017

Kotagal U

6

1 reference

25 November 2017

publication date

1 August 2001

1 reference

Pediatric Transplantation

25 November 2017

published in

1 reference

25 November 2017

volume

5

1 reference

25 November 2017

issue

4

1 reference

25 November 2017

page(s)

274-278

1 reference

Long-term results of pediatric liver transplantation: an analysis of 569 transplants

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2001.005004274.X

Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose. Analysis of the national multicenter study (1976 to 1985)

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2001.005004274.X

Neonatal hemochromatosis: outcomes of pharmacologic and surgical therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2001.005004274.X

Portal and systemic haemodynamic action of N-acetylcysteine in patients with stable cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2001.005004274.X

Anaphylactoid reaction to intravenous acetylcysteine associated with electrocardiographic abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2001.005004274.X

Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2001.005004274.X

Molecular therapies for vascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2001.005004274.X

Modification of vascular responses in xenotransplantation: inflammation and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2001.005004274.X

Predictors of the cost of liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2001.005004274.X

Resource utilization in liver transplantation: effects of patient characteristics and clinical practice. NIDDK Liver Transplantation Database Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2001.005004274.X

Payer status, but not race, affects the cost of liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2001.005004274.X

Prostaglandin E1 administration following orthotopic liver transplantation: a randomized prospective multicenter trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2001.005004274.X

7 January 2021

Prostaglandin E1 for the treatment of primary non-function of the donor organ in liver transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2001.005004274.X

7 January 2021

Efficacy of N-acetylcysteine as a hepatoprotective agent in liver transplantation: an experimental study

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2001.005004274.X

7 January 2021

The efficacy of N-acetylcysteine as a hepatoprotective agent in liver transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2001.005004274.X

7 January 2021

Does N-acetylcysteine improve hemodynamics and graft function in liver transplantation?

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2001.005004274.X

7 January 2021

Impact of N-acetylcysteine on the hepatic microcirculation after orthotopic liver transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2001.005004274.X

7 January 2021

N-acetylcysteine improves indocyanine green extraction and oxygen transport during hepatic dysfunction

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2001.005004274.X

7 January 2021

Prostaglandin E1 analogs do not improve renal function among either transplant or nontransplant patients: no further trials required

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2001.005004274.X

7 January 2021

Treatment of primary liver graft nonfunction with prostaglandin E1

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2001.005004274.X

7 January 2021

Gastric-outlet obstruction induced by prostaglandin therapy in neonates

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2001.005004274.X

7 January 2021

Intravenous N-acetylcysteine and lung glutathione of patients with pulmonary fibrosis and normals

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2001.005004274.X

7 January 2021

Early hepatocyte, endothelial, and bile duct cell injury after pediatric liver transplantation from cadaveric or living-related donors

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2001.005004274.X

7 January 2021

Accommodation of vascularized xenografts: expression of "protective genes" by donor endothelial cells in a host Th2 cytokine environment

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2001.005004274.X

7 January 2021

The impact of surgical complications after liver transplantation on resource utilization

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2001.005004274.X

7 January 2021

10.1034/J.1399-3046.2001.005004274.X

Identifiers

DOI

1 reference

25 November 2017

1 reference